A more recent score, the International Prognostic Index for CLL (IPI-CLL), implementing age, beta-2-microglobulin levels, and specific gene mutations status has improved prognosis estimation (2). This evidence concerns the gene B2M and B-cell chronic lymphocytic leukemia.